A collaborative study undertaken by the Navarrabiomed Biomedical Research Center (Pamplona, ??Navarre), the Institute of Neurosciences CSIC-UMH (Sant Joan d’Alacant, Valencian Community) and IRB Barcelona (Barcelona, ??Catalonia) shows that the administration of ranolazine, a drug currently used to treat heart conditions, improves the efficacy of current therapies for melanoma, in mouse models of this disease.
Latest News
Skin cancer screening guidelines can seem confusing – three skin cancer researchers explain when to consider getting checked
Protecting oneself from the summer sun and its damaging ultraviolet rays is often not straightforward. And public health messaging around when and how to be screened for skin cancer has become somewhat confusing.
Slip Slop Slap campaign effective for Queenslanders born after 1980 as general skin cancer rates rise
Having spent much of her childhood in the sun as a competitive swimmer, federal Senator Penny Allman-Payne’s skin cancer diagnosis was not surprising, but it was a wake up call.
Indian-origin researcher detects 135 new melanin genes responsible for pigmentation
Bajpai developed a novel method to detect and quantify the melanin-producing activity of melanocytes.